Multidisciplinary consensus on inhaled therapy in asthma

References

• World Health Organization. Asthma. [ cited 2020 Feb 14]. Available from: https://www.who.int/news-room/q-a-detail/asthma
   Google Scholar
• O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017;50(3):1701103.
   PubMed Web of Science ®Google Scholar
• Plaza V, Quirce S, Delgado J, et al. Grupo multidisciplinar de expertos “Asmaforum.” Multidisciplinary expert discussion. Uncontrolled asthma: causes, consequences and possible solutions. An Sist Sanit Navar. 2016;39(3):357–370.
   PubMed Web of Science ®Google Scholar
• Papi A, Brightling C, Pedersen SE, et al. Asthma. Lancet. 2018;391(10122):783–800.
   PubMed Web of Science ®Google Scholar
• Plaza V, Giner J, Rodrigo GJ, et al. Errors in the use of inhalers by health care professionals: a systematic review. J Allergy Clin Immunol Pract. 2018;6(3):987–995.
   PubMed Web of Science ®Google Scholar
• Asthma NAE and PP third expert panel on the diagnosis and management of. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute (US); 2007 [cited 2020 Feb 14]. Available from: https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma
   Google Scholar
• Scottish Intercollegiate Guidelines Network, British Thoracic Society, Scotland, Healthcare Improvement Scotland. British guideline on the management of asthma: a national clinical guideline. 2019 [cited 2020 Feb 14]. Available from: https://www.brit-thoracic.org.uk/about-us/pressmedia/2019/btssign-british-guideline-on-the-management-of-asthma-2019
   Google Scholar
• Global Strategy for Asthma Management and Prevention. 2019 GINA report [ cited 2020 Feb 14]. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf
   Google Scholar
• Guía Española para el Manejo del Asma. GEMA 4.4. Gemasma. [ cited 2020 Feb 14]. Available from: https://www.gemasma.com/
   Google Scholar
• Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311(7001):376–380.
   PubMed Web of Science ®Google Scholar
• The RAND/UCLA appropriateness method user’s manual | RAND. [ cited 2013 Jan 16]. Available from: http://www.rand.org/pubs/monograph_reports/MR1269.html
   Google Scholar
• Ribo P, Valero A, Bobolea I, et al. Impact of treatment prescription, adherence to treatment and use of inhalers in asthma control—results of the EFIMERA study. Abstracts TPS. Allergy. 2018;73(S105):370–702.
   PubMedGoogle Scholar
• Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J. 2002;19(2):246–251.
   PubMed Web of Science ®Google Scholar
• Westerik JAM, Carter V, Chrystyn H, et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma. 2016;53(3):321–329.
   PubMed Web of Science ®Google Scholar
• Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938.
   PubMed Web of Science ®Google Scholar
• Fernández Tena A, Casan Clarà P. Deposition of inhaled particles in the lungs. Arch Bronconeumol. 2012;48(7):240–246.
   PubMed Web of Science ®Google Scholar
• Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Med Devices (Auckl). 2015;8:131–139.
   PubMedGoogle Scholar
• de Boer AH, Gjaltema D, Hagedoorn P, et al. Can ‘extrafine’ dry powder aerosols improve lung deposition? Eur J Pharm Biopharm. 2015;96:143–151.
   PubMed Web of Science ®Google Scholar
• Usmani OS. Choosing the right inhaler for your asthma or COPD patient. TCRM. 2019;15:461–472.
   Google Scholar
• Valero A, Olaguibel J, Delgado J, et al., Dilemmas and new paradigms in asthma management. J Investig Allergol Clin Immunol. 2019;29(1):15–23.
   PubMed Web of Science ®Google Scholar
• Plaza Moral V, Giner Donaire J, Bustamante Madariaga V. GEMA inhaladores: terapia inhalada: fundamentos, dispositivos y aplicaciones prácticas. Madrid: Luzán 5 Health Consulting S.A.; 2018.
   Google Scholar
• Bousquet J, Boulet L-P, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med. 2007;101(12):2437–2446.
   PubMed Web of Science ®Google Scholar
• Kew KM, Karner C, Mindus SM, et al. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;12:CD009019.
   Google Scholar
• Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations: SMART vs. BUD/FORM and SAL/FLU. Int J Clin Pract. 2007;61(5):725–736.
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129–136.
   PubMed Web of Science ®Google Scholar
• Papi A, Corradi M, Pigeon-Francisco C, et al. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med. 2013;1(1):23–31.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368(9537):744–753.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Pizzichini E, Ställberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest. 2006;129(2):246–256.
   PubMed Web of Science ®Google Scholar
• Sobieraj DM, Weeda ER, Nguyen E, et al. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. JAMA. 2018;319(14):1485–1496.
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, D’Urzo A, Pauwels R, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J. 2005;26(5):819–828.
   PubMed Web of Science ®Google Scholar
• Vincken W, Levy ML, Scullion J, et al. Spacer devices for inhaled therapy: why use them, and how? ERJ Open Res. 2018;4(2):00065–2018.
   PubMedGoogle Scholar
• Plaza Moral V. Terapia inhalada teoría y práctica. Madrid: Luzán 5; 2011.
   Google Scholar
• Haidl P, Heindl S, Siemon K, et al. Inhalation device requirements for patients’ inhalation maneuvers. Respir Med. 2016;118:65–75.
   PubMed Web of Science ®Google Scholar
• Price DB, Román-Rodríguez M, McQueen RB, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol. 2017;5(4):1071–1081.e9.
   Web of Science ®Google Scholar
• Salvi S, Gogtay J, Aggarwal B. Use of breath-actuated inhalers in patients with asthma and COPD - an advance in inhalational therapy: a systematic review. Expert Rev Respir Med. 2014;8(1):89–99.
   PubMed Web of Science ®Google Scholar
• Bell D, Mansfield L, Lomax M. A randomized, crossover trial evaluating patient handling, preference, and ease of use of the fluticasone propionate/formoterol breath-triggered inhaler. J Aerosol Med Pulm Drug Deliv. 2017;30(6):425–434.
   PubMed Web of Science ®Google Scholar